Fig. 3.
Mibefradil induces cell death in MB spheres. A Left panel: representative bright field and fluorescent images of CHLA-01R cell spheres at before (day 5) and after (day 8) treatment with mibefradil (10 µM) or DMSO control. The scale bar is 300 μm. Right panel: quantitative analysis of PI fluorescence intensity of DMSO control and increasing concentrations of mibefradil. Results for each concentration were standardised to the non-treated control and expressed as fold change. Data represents mean ± standard deviation from three independent experiments with three replicates each. ns, not significant (p > 0.05), *p < 0.01, **p < 0.001 (one-way ANOVA with Dunnett multiple comparisons test compared with the non-treated 0 control group). B Live/dead analysis of MB spheres treated with different concentrations of mibefradil. Generated spheres were grown for 5 days and treated for 3 days. Single-cell suspension from dissociated spheres was stained with calcein-AM/propidium iodide and imaged using IN-Cell 2200 analyzer (20 × magnification). Left panel: exemplary fluorescence images. Right panel: quantitative analysis of acquired images using IN Carta image analysis software. The scale bar is 60 μm. Results for each concentration were standardised to the non-treated control and expressed as fold change. Data expressed as mean ± standard deviation from three independent assays with three replicates each. ns, not significant (p > 0.05), *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (two-way ANOVA with Dunnett multiple comparisons test compared with the non-treated control group)